We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
2851
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$256K ﹤0.01%
+2,695
New +$320K
HFFG icon
2852
HF Foods Group
HFFG
$78.1M
$255K ﹤0.01%
48,121
-5,289
-10% -$32.9K
RXDX
2853
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$255K ﹤0.01%
+10,369
New +$231K
RRBI icon
2854
Red River Bancshares
RRBI
$663M
$253K ﹤0.01%
5,009
-1,275
-20% -$69.2K
SPFI icon
2855
South Plains Financial
SPFI
$849M
$253K ﹤0.01%
10,947
-1,353
-11% -$31K
AMTX icon
2856
Aemetis
AMTX
$115M
$252K ﹤0.01%
+22,559
New +$356K
SMSI icon
2857
Smith Micro Software
SMSI
$15.7M
$252K ﹤0.01%
1,207
+613
+103% +$131K
PRLD icon
2858
Prelude Therapeutics
PRLD
$373M
$251K ﹤0.01%
8,775
-886
-9% -$31.5K
GTYH
2859
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$251K ﹤0.01%
35,263
-21,747
-38% -$132K
QTNT
2860
DELISTED
Quotient Limited Ordinary Shares
QTNT
$250K ﹤0.01%
1,716
-25
-1% -$4K
EOSE icon
2861
Eos Energy Enterprises
EOSE
$1.43B
$249K ﹤0.01%
+13,880
New +$224K
NODK icon
2862
NI Holdings
NODK
$318M
$249K ﹤0.01%
13,093
-2,073
-14% -$40K
DSP icon
2863
Viant Technology
DSP
$247M
$248K ﹤0.01%
8,327
-879
-10% -$28.3K
MBIO icon
2864
Mustang Bio
MBIO
$4.36M
$246K ﹤0.01%
99
+53
+115% +$130K
MTEM
2865
DELISTED
Molecular Templates, Inc.
MTEM
$244K ﹤0.01%
2,078
+172
+9% +$22.5K
IWS icon
2866
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$242K ﹤0.01%
+2,109
New +$242K
TX icon
2867
Ternium
TX
$10.2B
$242K ﹤0.01%
6,284
-7,773
-55% -$296K
ONIT
2868
Onity Group
ONIT
$311M
$242K ﹤0.01%
+7,814
New +$238K
MMAT
2869
DELISTED
Meta Materials Inc. Common Stock
MMAT
$242K ﹤0.01%
+323
New +$180K
MSON
2870
DELISTED
Misonix Inc
MSON
$241K ﹤0.01%
10,883
-1,496
-12% -$30.5K
ITI
2871
DELISTED
Iteris, Inc.
ITI
$240K ﹤0.01%
36,156
-3,171
-8% -$21.4K
DGICA icon
2872
Donegal Group Class A
DGICA
$725M
$239K ﹤0.01%
16,434
-160
-1% -$2.45K
VATE icon
2873
INNOVATE Corp
VATE
$101M
$239K ﹤0.01%
5,995
+1,575
+36% +$63.7K
TIG
2874
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$238K ﹤0.01%
15,750
+3,494
+29% +$57K
NATH icon
2875
Nathan's Famous
NATH
$403M
$237K ﹤0.01%
3,328
-1,355
-29% -$90.3K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.